| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 16.05 | 0.31 (+1.97%) | 9.07 - 16.13 | 92.5 thousand |
Market data as of 4:05PM 05/17/13. Quotes are delayed by at least 15 min.
| Open | 15.73 |
|---|---|
| Previous Close | 15.74 |
| Day's Range | 15.73 - 16.13 |
| Market Cap | 811.9M |
| Avg Volume (10 Day) | 85.6K |
| Price/Earnings (Trailing 12 Mo.) | 39.1x |
| Earnings Per Share (Trailing 12 Mo.) | 0.41 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Fail |
| Increased shareholder value? | Pass |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Pass |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Neutral |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Neutral |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Fail |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Fail |
| Has sufficient liquidity? | Pass |
WNS (Holdings) Limited Files Annual Report on Form 20-F
Business Wire - Monday 05/06/2013 3:08 PM ET
WNS to Present at Investor Conferences
Business Wire - Thursday 05/02/2013 6:00 AM ET
WNS Signs Contract Extension with Leading Pharmaceutical Company for High-End Research & Analytics Services
Business Wire - Monday 04/29/2013 6:33 AM ET
| WNS | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | -2.92% | |
| Net Income Growth (1yr) | -- | |
| Total Debt/Equity | 0.32 | |
| LT Debt/Equity | 0.11 | |
| Earnings Yield | 2.56% | |
| Price/Sales | 1.76 |
| Company | Last | Change |
|---|---|---|
| RPX Corp | 15.37 | -1.98% |
| Insperity Inc | 30.18 | +0.97% |
| Quad/Graphics Inc | 22.58 | +1.07% |
| TEAM, Inc. | 42.25 | -0.21% |
| comScore Inc | 20.25 | +3.85% |
Data is delayed by at least 15 min.